[Federal Register Volume 87, Number 144 (Thursday, July 28, 2022)]
[Notices]
[Pages 45345-45346]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-16152]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Request for Information (RFI): Inviting Comments and Suggestions 
on an ODS Strategic Plan 2022-2026

AGENCY: National Institutes of Health, HHS.

ACTION: Request for information.

-----------------------------------------------------------------------

SUMMARY: Since its inception in 1994, the National Institutes of Health 
(NIH), Office of Dietary Supplements (ODS) has used a structured 
planning process to develop five-year strategic plans. ODS is committed 
to engaging its stakeholders including representatives of the 
scientific community, industry, other federal agencies, and the public 
in the strategic planning process by soliciting their comments on the 
draft ODS Strategic Plan for Fiscal Years (FY) 2022-2026. Considering 
comments from representative stakeholder groups, and the general public 
will help ODS assess the outcomes of its investments and prioritize 
plans for the next five years.

DATES: The RFI is open for public comments and must be received by 
11:59:59 p.m. (ET) on August 31, 2022, to ensure consideration.

ADDRESSES: All comments must be submitted electronically to 
[email protected].

FOR FURTHER INFORMATION CONTACT: Please direct all inquiries to: 
Barbara Cohen at [email protected] or (301) 435-2920.

SUPPLEMENTARY INFORMATION: This notice is in accordance with the 21st 
Century Cures Act, wherein NIH institutes are required to regularly 
update their strategic plans. The purpose of the FY 2022-2026 ODS 
Strategic Plan (https://ods.od.nih.gov/About/StrategicPlan.aspx) is to 
communicate how ODS will advance its mission to support, coordinate, 
and disseminate the results of scientific research, and provide 
leadership to help expand the knowledge, scientific evidence, and 
understanding of dietary supplements, thus fostering an enhanced 
quality of life and health for the U.S. population. The plan 
articulates ODS' priorities in five key areas (goals):
    (1) Expand the scientific knowledge base on dietary supplements by 
stimulating and supporting a full range of biomedical research and by 
developing and contributing to relevant initiatives, workshops, 
meetings, and conferences;
    (2) Enhance the dietary supplement research workforce through 
training and career development and simultaneously support the 
development of programs for diverse researchers who are 
underrepresented in science;
    (3) Foster development and dissemination of research resources and 
tools to enhance the quality of dietary supplement research;
    (4) Translate dietary supplement research findings into useful 
information for consumers, health professionals, researchers, and 
policymakers; and
    (5) Coordinate and support the development of collaborative 
initiatives to address gaps in dietary supplement research.
    ODS has completed a draft of its Five-Year Strategic Plan for FY 
2022-2026 (https://ods.od.nih.gov/About/StrategicPlan.aspx) and is 
interested in receiving feedback from all interested parties on the 
following:
     Are there additional emerging public health issues that 
ODS can help address?
     Are there existing knowledge gaps that ODS can help 
address (not included in the current plan)?
     What can ODS do better to meet the needs of its 
stakeholders?
    ODS encourages organizations to submit a single response reflective 
of the views of the organization as a whole.
    Responses to this RFI are voluntary and may be submitted 
anonymously. Please do not include any personally identifiable 
information or any information that you do not wish to make public. 
Proprietary, classified, confidential, or sensitive information should 
not be included in your response. The NIH will use the information 
submitted in response to this RFI at its discretion. The NIH reserves 
the right to use any submitted information on public websites, in 
reports, in summaries of the state of the science, in any possible 
resultant solicitation(s), grant(s), or cooperative agreement(s), or in 
the development of future funding opportunity announcements. This RFI 
is for informational and planning purposes only and is not a 
solicitation for applications or an obligation on the part of the 
Government to provide support for any ideas identified in response to 
it. Please note that the Government will not pay for the preparation of 
any information submitted or for use of that information.
    We look forward to your input and hope that you will share this RFI 
opportunity with your colleagues.


[[Page 45346]]


    Dated: July 22, 2022.
Tara A. Schwetz,
Acting Principal Deputy Director, National Institutes of Health.
[FR Doc. 2022-16152 Filed 7-27-22; 8:45 am]
BILLING CODE 4140-01-P